Oak Ridge Investments LLC cut its holdings in shares of Cooper Companies, Inc. (The) (NYSE:COO) by 5.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,169 shares of the medical device company’s stock after selling 1,125 shares during the period. Oak Ridge Investments LLC’s holdings in Cooper Companies, Inc. (The) were worth $4,308,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. ProVise Management Group LLC grew its position in Cooper Companies, Inc. (The) by 0.6% during the 2nd quarter. ProVise Management Group LLC now owns 1,177 shares of the medical device company’s stock worth $282,000 after acquiring an additional 7 shares during the last quarter. YorkBridge Wealth Partners LLC grew its position in Cooper Companies, Inc. (The) by 2.1% during the 2nd quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock worth $126,000 after acquiring an additional 11 shares during the last quarter. Creative Planning grew its position in Cooper Companies, Inc. (The) by 0.8% during the 2nd quarter. Creative Planning now owns 1,909 shares of the medical device company’s stock worth $457,000 after acquiring an additional 16 shares during the last quarter. CIBC Asset Management Inc grew its position in Cooper Companies, Inc. (The) by 0.3% during the 2nd quarter. CIBC Asset Management Inc now owns 4,697 shares of the medical device company’s stock worth $1,125,000 after acquiring an additional 16 shares during the last quarter. Finally, Wedbush Securities Inc. grew its position in Cooper Companies, Inc. (The) by 1.0% during the 2nd quarter. Wedbush Securities Inc. now owns 1,783 shares of the medical device company’s stock worth $427,000 after acquiring an additional 18 shares during the last quarter. Institutional investors and hedge funds own 96.71% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was copied illegally and reposted in violation of international trademark & copyright laws. The correct version of this report can be read at https://www.thecerbatgem.com/2017/11/18/oak-ridge-investments-llc-has-4-31-million-stake-in-cooper-companies-inc-the-coo.html.

Shares of Cooper Companies, Inc. (COO) traded down $0.80 during trading on Friday, reaching $238.65. The company had a trading volume of 216,132 shares, compared to its average volume of 425,342. The firm has a market cap of $11,720.00, a P/E ratio of 25.32, a PEG ratio of 2.03 and a beta of 0.55. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.51 and a quick ratio of 1.29. Cooper Companies, Inc. has a twelve month low of $158.73 and a twelve month high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last released its earnings results on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.58 by $0.06. The firm had revenue of $556.00 million during the quarter, compared to analysts’ expectations of $552.32 million. Cooper Companies, Inc. (The) had a return on equity of 16.00% and a net margin of 16.45%. The company’s revenue was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.30 EPS. equities research analysts predict that Cooper Companies, Inc. will post 9.72 EPS for the current fiscal year.

In other Cooper Companies, Inc. (The) news, Director Gary S. Petersmeyer sold 3,977 shares of the stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $244.94, for a total transaction of $974,126.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.60% of the stock is currently owned by corporate insiders.

COO has been the topic of a number of research analyst reports. Robert W. Baird restated a “buy” rating and set a $273.00 price target (up from $267.00) on shares of Cooper Companies, Inc. (The) in a research report on Tuesday, September 12th. Zacks Investment Research raised Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $277.00 price objective on the stock in a report on Tuesday, August 29th. Jefferies Group LLC set a $250.00 price objective on Cooper Companies, Inc. (The) and gave the stock a “buy” rating in a report on Thursday, August 17th. Oppenheimer Holdings, Inc. reaffirmed a “hold” rating and set a $250.00 price objective on shares of Cooper Companies, Inc. (The) in a report on Tuesday, September 12th. Finally, Cleveland Research reaffirmed a “buy” rating on shares of Cooper Companies, Inc. (The) in a report on Tuesday, August 22nd. Six analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $260.22.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Stock Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related stocks with our FREE daily email newsletter.